Categories: NewsSpotlights

Faculty Highlight – Precision Oncology Conference, Salt Lake City, UT

Meet Chris Nevala-Plagemann, MD, Katie Kerrigan, DO, and Theresa Werner, MD!

In this week’s faculty highlight, we present Drs. Chris Nevala-Plagemann, Katie Kerrigan, and Theresa Werner.

These three doctors joined us as faculty at the Precision Oncology Conference in Salt Lake City, UT on October 7-8, 2022.

Our staff, Tiani, talked with Dr. Nevala-Plagemann, Dr. Kerrigan, and Dr. Werner to discuss their roles in the conference and how they relate to the Binaytara Foundation’s mission of improving access to cancer care through education, advocacy, and innovation.

Dr. Nevala-Plagemann, an oncologist at Huntsman Cancer Institute, believes that the Binaytara Foundation is making impact and was honored to be part of our conference.

Dr. Kerrigan is a head and neck, thyroid, and lung oncologist at Huntsman Cancer Institute. She is interested in decreasing health disparities and was excited to support our mission.

Lastly, Dr. Werner is an oncologist at Huntsman Cancer Institute and she was the co-chair at the Precision Oncology Conference. She is passionate about access to cancer care and our mission resonates with her.

Watch the video to hear more!


The Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal. Donate here to change lives!

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

7 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

7 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

7 months ago